157 related articles for article (PubMed ID: 23432082)
1. Recalcitrant pemphigus herpetiformis with high titer of immunoglobulin G antibody to desmoglein 1 and positive IgG antibody to desmocollin 3, elevating thymus and activation-regulated chemokine.
Matsukura S; Takahashi K; Hirokado M; Ikezawa Y; Nakamura K; Fukuda S; Hashimoto T; Ikezawa Z; Aihara M; Kambara T
Int J Dermatol; 2014 Aug; 53(8):1023-6. PubMed ID: 23432082
[No Abstract] [Full Text] [Related]
2. IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
Kopp T; Sitaru C; Pieczkowski F; Schneeberger A; Födinger D; Zillikens D; Stingl G; Karlhofer FM
J Dtsch Dermatol Ges; 2006 Dec; 4(12):1045-50. PubMed ID: 17176412
[TBL] [Abstract][Full Text] [Related]
3. Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3.
Ansai O; Shimomura Y; Fujimoto A; Sakai A; Tsuchida Y; Hayashi R; Shigehara Y; Hama N; Abe R
J Dermatol; 2017 Jan; 44(1):104-105. PubMed ID: 27177601
[No Abstract] [Full Text] [Related]
4. Pemphigus herpetiformis with IgG autoantibodies to desmoglein 1 and desmocollin 1.
On HR; Hashimoto T; Kim SC
Br J Dermatol; 2015 Apr; 172(4):1144-6. PubMed ID: 25244249
[No Abstract] [Full Text] [Related]
5. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
Green MG; Bystryn JC
Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
[TBL] [Abstract][Full Text] [Related]
6. Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus.
Kasuya A; Moriki M; Tatsuno K; Hirakawa S; Tokura Y
Acta Derm Venereol; 2013 Mar; 93(2):181-2. PubMed ID: 22948906
[No Abstract] [Full Text] [Related]
7. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
[TBL] [Abstract][Full Text] [Related]
8. IgA pemphigus with paraneoplastic pemphigus-like clinical features showing IgA antibodies to desmoglein 1/3 and desmocollin 3, and IgG and IgA antibodies to the basement membrane zone.
Ueda A; Ishii N; Temporin K; Yamazaki R; Murakami F; Fukuda S; Hamada T; Dainichi T; Kyoya M; Saito C; Matsunaga R; Kimura S; Kawakami T; Soma Y; Hashimoto T
Clin Exp Dermatol; 2013 Jun; 38(4):370-3. PubMed ID: 23517469
[TBL] [Abstract][Full Text] [Related]
9. Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy.
Aoyama Y; Moriya C; Kamiya K; Nagai M; Rubenstein D; Iwatsuki K; Kitajima Y
Eur J Dermatol; 2011; 21(1):58-61. PubMed ID: 21233063
[TBL] [Abstract][Full Text] [Related]
10. An alternate explanation for the decrease in pemphigus antibodies with combination treatment of double-filtration plasmapheresis and IVIg.
Habib N; Bystryn JC
Eur J Dermatol; 2009; 19(2):190; author reply 191. PubMed ID: 19106059
[No Abstract] [Full Text] [Related]
11. Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3.
Kozlowska A; Hashimoto T; Jarzabek-Chorzelska M; Amagai A; Nagata Y; Strasz Z; Jablonska S
J Am Acad Dermatol; 2003 Jan; 48(1):117-22. PubMed ID: 12522381
[TBL] [Abstract][Full Text] [Related]
12. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
13. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
[No Abstract] [Full Text] [Related]
14. Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus.
Czernik A; Beutner EH; Bystryn JC
J Am Acad Dermatol; 2008 May; 58(5):796-801. PubMed ID: 18423257
[TBL] [Abstract][Full Text] [Related]
15. IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses.
Nakajima K; Hashimoto T; Nakajima H; Yokogawa M; Ikeda M; Kodama H
J Dermatol; 2007 Nov; 34(11):757-60. PubMed ID: 17973815
[TBL] [Abstract][Full Text] [Related]
16. Anti-desmoglein 1 IgG/IgA pemphigus associated with thymoma.
Reichel A; Benoit S; Giner T; Schmidt E; Goebeler M; Stoevesandt J
J Dtsch Dermatol Ges; 2017 Nov; 15(11):1147-1148. PubMed ID: 29030953
[No Abstract] [Full Text] [Related]
17. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus Autoantibodies to Desmocollin 3 but Not to Desmocollin 1 Directly Block Heterophilic Desmoglein/Desmocollin Transinteraction.
Ishii K; Ishii N; Ishiko A; Hashimoto T
J Invest Dermatol; 2024 Jun; 144(6):1394-1397. PubMed ID: 38101510
[No Abstract] [Full Text] [Related]
19. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.
Feldman RJ; Christen WG; Ahmed AR
Br J Dermatol; 2012 Mar; 166(3):511-7. PubMed ID: 21967407
[TBL] [Abstract][Full Text] [Related]
20. Detection of IgG antibodies to desmoglein 3 and desmocollins 2 and 3 in mucosal dominant-type pemphigus vulgaris with severe pharyngalgia and hyperemia of the bulbar conjunctiva.
Makino T; Hara H; Mizawa M; Seki Y; Hayashi M; Ishii N; Hashimoto T; Shimizu T
Eur J Dermatol; 2015; 25(6):619-20. PubMed ID: 26463887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
